Mark Carney entered office with a clear message: Canada needs action, not delay. In his first 100 days as prime minister, Carney has moved quickly to turn campaign priorities into legislative results, with a national push to dismantle internal trade barriers before Canada Day. A fast start Mark Carney became Canada’s 24th prime minister […]
First 100 Days: Mark Carney in Motion Read More »
Canada’s regulatory regime is criticized for preventing the adaptation of innovative technologies. The Conference Board of Canada found in 2021 that Canada ranked 11th among 16 countries and it was provided a “C” grade for extracting social and economic benefits from innovation. Adding to these observations, the 2021 OECD economic survey gave Canada a “poor”
Advanced Therapeutic Products: Canada’s Health & Biosciences Regulatory Sandbox Read More »
Highlights Cannabis use for medical purposes bypassed the traditional drug policy protocols before the introduction of the Cannabis Act through successive court decisions suspending it from the Canadian Substance Drugs Act (CSDA). Psychedelics, such as psilocybin and MDMA, are following Health Canada’s standard protocols for clinical trial phases. Full legalization of psychedelics for recreational use
Psychedelic Policies in Canada: Separating Hallucinations from Reality Read More »
